L740-0332 Screening compound: N-(4-chlorophenyl)-4-({[(4-fluorophenyl)methyl]carbamoyl}methyl)-3-oxopiperazine-1-carboxamide

L740-0332 Screening compound: N-(4-chlorophenyl)-4-({[(4-fluorophenyl)methyl]carbamoyl}methyl)-3-oxopiperazine-1-carboxamide
L740-0332 Screening compound: N-(4-chlorophenyl)-4-({[(4-fluorophenyl)methyl]carbamoyl}methyl)-3-oxopiperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L740-0332
N-(4-chlorophenyl)-4-({[(4-fluorophenyl)methyl]carbamoyl}methyl)-3-oxopiperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L740-0332

Molecular Formula

C20H20ClFN4O3 (C20 H20 ClFN4 O3)

Compound Name

N-(4-chlorophenyl)-4-({[(4-fluorophenyl)methyl]carbamoyl}methyl)-3-oxopiperazine-1-carboxamide

IUPAC name

N-(4-chlorophenyl)-4-({[(4-fluorophenyl)methyl]carbamoyl}methyl)-3-oxopiperazine-1-carboxamide

SMILES

O=C(CN(CCN(C1)C(Nc(cc2)ccc2Cl)=O)C1=O)NCc(cc1)ccc1F

InChI

InChI=1S/C20H20ClFN4O3/c21-15-3-7-17(8-4-15)24-20(29)26-10-9-25(19(28)13-26)12-18(27)23-11-14-1-5-16(22)6-2-14/h1-8H,9-13H2,(H,23,27)(H,24,29)

InChI Key

UFDHSWALYXJDJE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27473364

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.86

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.147

Distribution Coefficient, logD

2.147

Water Solubility, LogSw

-3.03

Polar Surface Area

66.817

Acid Dissociation Constant (pKa)

12.24

Base Dissociation Constant (pKb)

0.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

L740-0332 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L740-0332 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L740-0332?
Check Price and Availability of L740-0332, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L740-0332 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L740-0332
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L740-0332
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L740-0332 available by request